MiR-138: A promising therapeutic target for cancer

Tumour Biol. 2017 Apr;39(4):1010428317697575. doi: 10.1177/1010428317697575.

Abstract

MicroRNAs are small noncoding RNAs which regulate gene expressions at post-transcriptional level by binding to the 3'-untranslated region of target messenger RNAs. Growing evidences highlight their pivotal roles in various biological processes of human cancers. Among them, miR-138, generating from two primary transcripts, pri-miR-138-1 and pri-miR-138-2, expresses aberrantly in different cancers and is extensively studied in cancer network. Importantly, studies have shown that miR-138 acts as a tumor suppressor by targeting many target genes, which are related to proliferation, apoptosis, invasion, and migration. Additionally, some researches also discover that miR-138 can sensitize tumors to chemotherapies. In this review, we summarize the expression of miR-138 on regulatory mechanisms and tumor biological processes, which will establish molecular basis on the usage of miR-138 in clinical applications in the future.

Keywords: MicroRNA; biological processes; cancers; microRNA-138.

Publication types

  • Review

MeSH terms

  • Apoptosis
  • Cell Proliferation
  • Gene Expression Regulation, Neoplastic
  • Humans
  • MicroRNAs / physiology*
  • Neoplasm Invasiveness
  • Neoplasm Metastasis
  • Neoplasms / drug therapy
  • Neoplasms / genetics*
  • Neoplasms / pathology

Substances

  • MIRN138 microRNA, human
  • MicroRNAs